Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bile acid distributions, sex-specificity, and prognosis in colorectal cancer. | Biol Sex Differ | 2022 | 36274154 | PubTator, text mining | PubMed |
| Presence of entry receptors and viral markers suggest a low level of placental replication of hepatitis B virus in a proportion of pregnant women infected with chronic hepatitis B. | Sci Rep | 2022 | 36272995 | PubTator, text mining | PubMed |
| Effects of Sedi Herba (Sedum sarmentosum) on attenuating cholestasis by the activation of the farnesoid x receptor (FXR)-mediated signaling. | Biomed Pharmacother | 2022 | 36271579 | PubTator, text mining | PubMed |
| Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma. | Front Mol Biosci | 2022 | 36267158 | PubTator, text mining | PubMed |
| Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinoma. | Front Genet | 2022 | 36246607 | PubTator, text mining | PubMed |
| Physiologically relevant microsystems to study viral infection in the human liver. | Front Microbiol | 2022 | 36246284 | PubTator, text mining | PubMed |
| Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus. | Int J Mol Sci | 2022 | 36233317 | PubTator, text mining | PubMed |
| Virus-Associated Nephropathies: A Narrative Review. | Int J Mol Sci | 2022 | 36233315 | PubTator, text mining | PubMed |
| Safe and Efficient Sigma1 Ligand: A Potential Drug Candidate for Multiple Sclerosis. | Int J Mol Sci | 2022 | 36233193 | PubTator, text mining | PubMed |
| In Vitro Models for Studying Chronic Drug-Induced Liver Injury. | Int J Mol Sci | 2022 | 36232728 | PubTator, text mining | PubMed |
| Direct Differentiation of Human Embryonic Stem Cells to 3D Functional Hepatocyte-like Cells in Alginate Microencapsulation Sphere. | Cells | 2022 | 36231094 | PubTator, text mining | PubMed |
| Murine Models of Chronic Viral Infections and Associated Cancers. | Mol Biol | 2022 | 36217336 | PubTator, text mining | PubMed |
| Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts. | Wellcome Open Res | 2022 | 36212217 | PubTator, text mining | PubMed |
| Impact of pregnancy related hormones on drug metabolizing enzyme and transport protein concentrations in human hepatocytes. | Front Pharmacol | 2022 | 36210832 | PubTator, text mining | PubMed |
| APOBEC3B: Future direction of liver cancer research. | Front Oncol | 2022 | 36203448 | PubTator, text mining | PubMed |
| Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19. | Comput Biol Med | 2022 | 36201886 | PubTator, text mining | PubMed |
| The use of the normal tissue non-complication probability (NTCP0) methodology as a new alternative of assessing side-effects in brachytherapy treatments. | Rep Pract Oncol Radiother | 2022 | 36196423 | PubTator, text mining | PubMed |
| Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cells. | Biopharm Drug Dispos | 2022 | 36195987 | PubTator, text mining | PubMed |
| iTRAQ Quantitative Proteomic Analysis of Different Expressed Proteins and Signal Pathways in Bakuchiol-Induced Hepatotoxicity. | Evid Based Complement Alternat Med | 2022 | 36193146 | PubTator, text mining | PubMed |
| Development and validation of a microenvironment-related prognostic model for hepatocellular carcinoma patients based on histone deacetylase family. | Transl Oncol | 2022 | 36191460 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=34